Your browser doesn't support javascript.
loading
Prognostic factors after surgical resection of N1 non-small cell lung cancer.
Mordant, P; Pricopi, C; Legras, A; Arame, A; Foucault, C; Dujon, A; Le Pimpec-Barthes, F; Riquet, M.
Afiliação
  • Mordant P; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Descartes University, Paris, France.
  • Pricopi C; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Descartes University, Paris, France.
  • Legras A; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Descartes University, Paris, France.
  • Arame A; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Descartes University, Paris, France.
  • Foucault C; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Descartes University, Paris, France.
  • Dujon A; Cedar Surgical Centre, Bois Guillaume, France.
  • Le Pimpec-Barthes F; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Descartes University, Paris, France.
  • Riquet M; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Descartes University, Paris, France. Electronic address: marc.riquet@egp.aphp.fr.
Eur J Surg Oncol ; 41(5): 696-701, 2015 May.
Article em En | MEDLINE | ID: mdl-25454825
ABSTRACT

OBJECTIVES:

Non-small cell lung carcinoma (NSCLC) with N1 involvement is associated with 5-year survival rates ranging from 7% to 55%. Numerous factors have been independently reported to explain this heterogeneous prognosis, but their relative weight on long-term survival is unknown.

METHODS:

Patients who underwent surgical resection for NSCLC in two French centers from 1993 to 2010 were prospectively recorded and retrospectively reviewed. The overall survival (OS) of patients undergoing first-line surgery for pN1 disease was analyzed according to the type of extension, number of metastatic LN, number and anatomic location of metastatic stations.

RESULTS:

The study group included 450 patients (male 80.2%, mean age 63.3 ± 9.9 years, 5-year overall survival 46%). The number of metastatic station was 1 in 340 (75.6%, single-station disease) and ≥2 in 110 patients (24.4%, multi-station disease). The number of metastatic stations was correlated with the number of metastatic LN (p < .001), and associated with adverse OS (p = .0014). The presence of intralobar metastatic LN (station 12-13-14) was associated with a mechanism of direct extension (p < .001), but did not impact OS (p = .71). The location of metastatic stations was of prognostic significance only in case of multi-station disease, with hilar (station 10) involvement being associated with adverse OS (p = .005). The 110 patients with multi-station pN1 disease and the 134 patients operated on for single-station pN0N2 (skip-N2) disease during the study period yield comparable outcome (p = .52).

CONCLUSIONS:

In patients with resected pN1 NSCLC, the number of metastatic stations and their location in case of multi-station disease have a prognostic value.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonectomia / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Linfonodos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Surg Oncol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonectomia / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Linfonodos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Surg Oncol Ano de publicação: 2015 Tipo de documento: Article